116 related articles for article (PubMed ID: 11890935)
1. Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Mutat Res; 2002 Mar; 500(1-2):67-74. PubMed ID: 11890935
[TBL] [Abstract][Full Text] [Related]
2. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
Campbell MR; Thang TY; Jirik FR; Andrew SE
Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
[TBL] [Abstract][Full Text] [Related]
3. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.
Baross-Francis A; Milhausen MK; Andrew SE; Jevon G; Jirik FR
Carcinogenesis; 2000 Jun; 21(6):1259-62. PubMed ID: 10837019
[TBL] [Abstract][Full Text] [Related]
4. Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability.
Baross-Francis A; Andrew SE; Penney JE; Jirik FR
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8739-43. PubMed ID: 9671748
[TBL] [Abstract][Full Text] [Related]
5. Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6-phenolimidazo [4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Oncogene; 2001 Sep; 20(42):6066-72. PubMed ID: 11593414
[TBL] [Abstract][Full Text] [Related]
6. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.
Andrew SE; McKinnon M; Cheng BS; Francis A; Penney J; Reitmair AH; Mak TW; Jirik FR
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1126-30. PubMed ID: 9448296
[TBL] [Abstract][Full Text] [Related]
7. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
[TBL] [Abstract][Full Text] [Related]
9. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice.
Andrew SE; Reitmair AH; Fox J; Hsiao L; Francis A; McKinnon M; Mak TW; Jirik FR
Oncogene; 1997 Jul; 15(2):123-9. PubMed ID: 9244348
[TBL] [Abstract][Full Text] [Related]
10. Msh2 deficiency increases the mutation frequency in all parts of the mouse colon.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Environ Mol Mutagen; 2002; 40(4):243-50. PubMed ID: 12489114
[TBL] [Abstract][Full Text] [Related]
11. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
12. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes.
Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T
DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017
[TBL] [Abstract][Full Text] [Related]
13. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
14. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
Qin X; Zhou H; Liu L; Gerson SL
Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous tandem-base mutations (TBM) show dramatic tissue, age, pattern and spectrum specificity.
Hill KA; Wang J; Farwell KD; Sommer SS
Mutat Res; 2003 Jan; 534(1-2):173-86. PubMed ID: 12504766
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.
Qing Y; Gerson SL
PLoS One; 2017; 12(8):e0182175. PubMed ID: 28767666
[TBL] [Abstract][Full Text] [Related]
18. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
[TBL] [Abstract][Full Text] [Related]
20. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
